{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:51:58Z","timestamp":1765828318662,"version":"build-2065373602"},"reference-count":45,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Hubei Province, China","award":["2021CFB361","2021EHB025"],"award-info":[{"award-number":["2021CFB361","2021EHB025"]}]},{"name":"International Scientific and Technological Cooperation Project of Hubei Province, China","award":["2021CFB361","2021EHB025"],"award-info":[{"award-number":["2021CFB361","2021EHB025"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Research Question: To compare the cumulative live birth rate (CLBR) per oocyte retrieval cycle of a conventional progestin-primed ovarian stimulation (cPPOS) regimen with a flexible progestin-primed ovarian stimulation (fPPOS) regimen in poor ovarian response patients, according to POSEIDON criteria. Design: Poor ovarian response women, according to POSEIDON criteria, who underwent the first PPOS protocol for in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) between January 2018 and December 2020 were included. The fPPOS group involved 113 participants, and the cPPOS group included 1119 participants. In the cPPOS group, medroxyprogesterone acetate (MPA) (10 mg\/d) was administrated on the gonadotropin injection the same day as gonadotropin injections in the cPPOS group, while MPA was started either on the day when the leading follicle with mean diameter &gt; 12mm was present and\/or serum E2 was &gt;300 pg\/mL in the fPPOS protocol group. The primary outcome was CLBR. Results: The fPPOS protocol had higher CLBR per oocyte retrieval cycle compared to the cPPOS group, even without a statistically significant difference (29.6% vs. 24.9%, p = 0.365). The fPPOS group had fewer numbers of retrieved oocytes (2.87 \u00b1 2.03 vs. 3.76 \u00b1 2.32, p &lt; 0.001) but a higher MII oocyte rate (89.8% vs. 84.7%, p = 0.016). In addition, the number of available embryos in the two groups was comparable (1.37 \u00b1 1.24 vs. 1.63 \u00b1 1.38, p = 0.095). There were five women in the fPPOS group, and 86 women in the cPPOS group had a premature LH surge (4.2% vs. 6.8%, p = 0.261). In the fPPOS group, there was one instance of premature ovulation, while in the cPPOS group, there were six occurrences of premature ovulation (0.8 vs. 0.5%, p = 1.000). Conclusion(s): The novel fPPOS protocol appears to achieve higher CLBR even without significant differences and with MPA consumption compared with cPPOS protocol in low-prognosis patients.<\/jats:p>","DOI":"10.3390\/jcm12185775","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T10:26:43Z","timestamp":1693909603000},"page":"5775","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of Cumulative Live Birth Rates between Flexible and Conventional Progestin-Primed Ovarian Stimulation Protocol in Poor Ovarian Response Patients According to POSEIDON Criteria: A Cohort Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[{"name":"Reproductive Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"},{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3128-3117","authenticated-orcid":false,"given":"Yifan","family":"Chu","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yao","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjiang","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yue","sequence":"additional","affiliation":[{"name":"Reproductive Medical Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/dead038","article-title":"The BISTIM study: A randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF","volume":"38","author":"Massin","year":"2023","journal-title":"Hum. Reprod."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: From a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Abu-Musa, A., Haahr, T., and Humaidan, P. (2020). Novel Physiology and Definition of Poor Ovarian Response; Clinical Recommendations. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062110"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpobgyn.2022.05.003","article-title":"POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data research","volume":"85 Pt B","author":"Esteves","year":"2022","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/humrep\/dez051","article-title":"Cumulative live birth rates in low-prognosis women","volume":"34","author":"Leijdekkers","year":"2019","journal-title":"Hum. Reprod."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/humrep\/deaa183","article-title":"SAY NO to mild ovarian stimulation for all poor responders: It is time to realize that not all poor responders are the same","volume":"35","author":"Polyzos","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","article-title":"Progestins for pituitary suppression during ovarian stimulation for ART: A comprehensive and systematic review including meta-analyses","volume":"27","author":"Ata","year":"2021","journal-title":"Hum. Reprod Update"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7447","DOI":"10.1038\/s41598-017-07773-w","article-title":"Effect of Frozen Embryo Transfer and Progestin-primed Ovary Stimulation on IVF outcomes in women with high body mass index","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.fertnstert.2016.04.006","article-title":"Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection","volume":"106","author":"Qin","year":"2016","journal-title":"Fertil. Steril."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11927","DOI":"10.1038\/s41598-017-12151-7","article-title":"Use of medroxyprogesterone acetate in women with ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"7","author":"Guo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF\/ICSI Cycle: A Randomized Clinical Trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1056\/NEJMoa1705334","article-title":"Transfer of Fresh versus Frozen Embryos in Ovulatory Women","volume":"378","author":"Shi","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1513873","article-title":"Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","article-title":"Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology","volume":"112","author":"Yildiz","year":"2019","journal-title":"Fertil. Steril."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/14647273.2020.1794060","article-title":"Effectiveness of the flexible progestin primed ovarian stimulation protocol compared to the flexible GnRH antagonist protocol in women with decreased ovarian reserve","volume":"25","author":"Turkgeldi","year":"2022","journal-title":"Hum. Fertil."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","article-title":"The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: A randomized controlled trial and molecular mechanism study","volume":"35","author":"Xu","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"587051","DOI":"10.3389\/fendo.2021.587051","article-title":"Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines","volume":"12","author":"Esteves","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1156620","DOI":"10.3389\/fendo.2023.1156620","article-title":"Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: A propensity score-matched cohort study","volume":"14","author":"Du","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_20","first-page":"2703","article-title":"Cumulative live birth rate: Time for a consensus?","volume":"30","author":"Maheshwari","year":"2015","journal-title":"Hum. Reprod."},{"key":"ref_21","first-page":"1786","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"32","author":"Adamson","year":"2017","journal-title":"Hum. Reprod."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"617.e1","DOI":"10.1016\/j.ajog.2019.05.043","article-title":"The combined impact of maternal age and body mass index on cumulative live birth following in vitro fertilization","volume":"221","author":"Goldman","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-M\u00fcllerian hormone levels are negatively related to Follicular Output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"Genro","year":"2011","journal-title":"Hum. Reprod."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3389\/fendo.2018.00589","article-title":"Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index","volume":"9","author":"Alviggi","year":"2018","journal-title":"Front. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12958-023-01069-7","article-title":"Stop GnRH-agonist\/GnRH-antagonist protocol: A different insight on ovarian stimulation for IVF","volume":"21","author":"Orvieto","year":"2023","journal-title":"Reprod. Biol. Endocrinol. RB&E"},{"key":"ref_26","first-page":"1","article-title":"ESHRE guideline: Ovarian stimulation for IVF\/ICSI\u2020","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"797227","DOI":"10.3389\/fendo.2021.797227","article-title":"The Comparison of Fixed and Flexible Progestin Primed Ovarian Stimulation on Mature Oocyte Yield in Women at Risk of Premature Ovarian Insufficiency","volume":"12","author":"Kalafat","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"644456","DOI":"10.3389\/fendo.2021.644456","article-title":"Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients according to POSEIDON Criteria: A Cohort Study","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.2147\/DDDT.S263138","article-title":"Live-Birth Outcomes and Congenital Malformations After Progestin-Primed Ovarian Stimulation in Maternal Endometriosis","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10815-020-01755-0","article-title":"Impact of progestin ovarian stimulation on newborn outcomes: A meta-analysis","volume":"37","author":"Zolfaroli","year":"2020","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil. Steril."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1365-2826.2007.01613.x","article-title":"Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: Effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms","volume":"19","author":"Attardi","year":"2007","journal-title":"J. Neuroendocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102049","DOI":"10.1016\/j.jogoh.2020.102049","article-title":"A meta-analysis of the efficacy of progestin-primed ovarian stimulation with medroxyprogesterone acetate in ovulation induction in poor ovarian responders","volume":"50","author":"Cai","year":"2021","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_34","unstructured":"Liang, X.Y., Fang, C., Huang, R., and Silber, S.J. (2018). Clinical Techniques of Assisted Reproduction\u2014Practice and Improvement, Chinese People\u2019s Publishing House."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100470","DOI":"10.1016\/j.repbio.2020.100470","article-title":"New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone","volume":"21","author":"Iwami","year":"2020","journal-title":"Reprod. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fendo.2020.00129","article-title":"Efficacy of Different Progestins in Women With Advanced Endometriosis Undergoing Controlled Ovarian Hyperstimulation for in vitro Fertilization-A Single-Center Non-inferiority Randomized Controlled Trial","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-Primed Ovarian Stimulation with Dydrogesterone versus Medroxyprogesterone Acetate inWomen with Polycystic Ovarian Syndrome for in vitro Fertilization: A Retrospective Cohort Study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: A randomized controlled trial including 516 first IVF\/ICSI cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1471-0528.14622","article-title":"The pregnancy outcome of progestin-primed ovarian stimulation using 4 versus 10 mg of medroxyprogesterone acetate per day in infertile women undergoing in vitro fertilisation: A randomised controlled trial","volume":"124","author":"Dong","year":"2017","journal-title":"BJOG"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/jog.14267","article-title":"Dydrogesterone-primed ovarian stimulation is an effective alternative to gonadotropin-releasing hormone antagonist protocol for freeze-all cycles in polycystic ovary syndrome","volume":"46","author":"Gurbuz","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","article-title":"New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology","volume":"298","author":"Iwami","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/DDDT.S210228","article-title":"Neonatal outcomes and congenital malformations in children born after dydrogesterone application in progestin-primed ovarian stimulation protocol for IVF: A retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cesarano, S., Pirtea, P., Benammar, A., De Ziegler, D., Poulain, M., Revelli, A., Benedetto, C., Vall\u00e9e, A., and Ayoubi, J.M. (2022). Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?. J. Clin. Med., 11.","DOI":"10.3390\/jcm11082099"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3389\/fendo.2019.00614","article-title":"Management Strategies for POSEIDON Groups 3 and 4","volume":"10","author":"Haahr","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/deab152","article-title":"Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: A real-world evidence study of 9073 patients","volume":"36","author":"Esteves","year":"2021","journal-title":"Hum. Reprod."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:46:43Z","timestamp":1760129203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/18\/5775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":45,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["jcm12185775"],"URL":"https:\/\/doi.org\/10.3390\/jcm12185775","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2023,9,5]]}}}